Articles | Volume 10, issue 6
https://doi.org/10.5194/jbji-10-561-2025
https://doi.org/10.5194/jbji-10-561-2025
Original full-length article
 | 
09 Dec 2025
Original full-length article |  | 09 Dec 2025

Effect of novel antimicrobial blue light-emitting optical fiber on vancomycin-resistant Enterococcus faecium and carbapenemase-producing Klebsiella pneumoniae

Megan H. Goh, Barbara Körber-Irrgang, Lucy L. Hederick, Robert A. Rabiner, Hilmar Wisplinghoff, Antonia F. Chen, Nathalie Jazmati, and Santiago A. Lozano-Calderon

Viewed

Total article views: 269 (including HTML, PDF, and XML)
HTML PDF XML Total BibTeX EndNote
196 57 16 269 9 13
  • HTML: 196
  • PDF: 57
  • XML: 16
  • Total: 269
  • BibTeX: 9
  • EndNote: 13
Views and downloads (calculated since 09 Dec 2025)
Cumulative views and downloads (calculated since 09 Dec 2025)

Viewed (geographical distribution)

Total article views: 264 (including HTML, PDF, and XML) Thereof 264 with geography defined and 0 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 
Latest update: 03 Feb 2026
Download
Short summary
This study explored whether blue light could help treat difficult joint implant infections caused by drug-resistant bacteria. A new optical fiber that delivers light evenly was tested in the lab. Blue light reduced bacteria more with higher power and longer exposure. These findings suggest that this fiber could support future light-based treatments for deep surgical infections.
Share